Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ubp1
|
ENSMUSG00000009741.8 | upstream binding protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_113969020_113969322 | Ubp1 | 54 | 0.966857 | -0.48 | 2.4e-04 | Click! |
chr9_113969518_113969679 | Ubp1 | 373 | 0.803762 | -0.44 | 7.0e-04 | Click! |
chr9_113941501_113941655 | Ubp1 | 9924 | 0.198414 | -0.44 | 7.2e-04 | Click! |
chr9_113969738_113969932 | Ubp1 | 610 | 0.606522 | -0.43 | 9.1e-04 | Click! |
chr9_113968750_113968926 | Ubp1 | 387 | 0.825913 | -0.42 | 1.3e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_13654565_13655321 | 22.12 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr17_13590938_13591623 | 12.77 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr3_82406341_82406796 | 10.58 |
Map9 |
microtubule-associated protein 9 |
26495 |
0.24 |
chr9_124439906_124440949 | 10.21 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chrX_102003725_102004324 | 9.29 |
Nhsl2 |
NHS-like 2 |
1020 |
0.5 |
chr7_99267195_99268129 | 8.55 |
Map6 |
microtubule-associated protein 6 |
173 |
0.76 |
chr9_41697271_41698297 | 8.42 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr4_107680369_107681106 | 8.27 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
223 |
0.9 |
chr8_4206127_4207837 | 7.85 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr16_46009777_46011157 | 7.76 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
249 |
0.91 |
chr12_3236518_3237725 | 7.45 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr13_83744885_83745867 | 7.39 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6513 |
0.13 |
chr16_77593811_77594374 | 7.33 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
264 |
0.83 |
chr9_40268412_40269319 | 7.31 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr1_155233440_155234889 | 7.26 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr7_139834023_139834682 | 6.52 |
Adgra1 |
adhesion G protein-coupled receptor A1 |
13 |
0.97 |
chr11_42000451_42000692 | 6.43 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
39 |
0.99 |
chr6_55451539_55452374 | 6.34 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
22 |
0.98 |
chr10_75994691_75995012 | 6.24 |
Gm16220 |
predicted gene 16220 |
859 |
0.4 |
chr10_106469332_106470360 | 6.23 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
493 |
0.82 |
chr18_81251894_81252538 | 6.22 |
Gm30192 |
predicted gene, 30192 |
12475 |
0.22 |
chr1_20905728_20906173 | 6.13 |
Gm24171 |
predicted gene, 24171 |
9590 |
0.12 |
chr11_88356603_88356961 | 6.12 |
Gm15893 |
predicted gene 15893 |
491 |
0.76 |
chr13_83985066_83985623 | 6.09 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr5_8367250_8367622 | 6.05 |
Adam22 |
a disintegrin and metallopeptidase domain 22 |
546 |
0.77 |
chr6_28842333_28842923 | 6.05 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
6279 |
0.2 |
chr12_51001833_51002010 | 6.04 |
Gm40421 |
predicted gene, 40421 |
2952 |
0.27 |
chr3_134339308_134339650 | 5.94 |
Gm43558 |
predicted gene 43558 |
17813 |
0.17 |
chr6_55452389_55452881 | 5.94 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
458 |
0.84 |
chr5_100108777_100109262 | 5.93 |
Tmem150c |
transmembrane protein 150C |
13777 |
0.15 |
chr6_50412177_50412471 | 5.90 |
Osbpl3 |
oxysterol binding protein-like 3 |
15174 |
0.23 |
chr3_68824497_68825036 | 5.86 |
Gm7270 |
predicted gene 7270 |
21313 |
0.12 |
chr7_141468254_141469266 | 5.86 |
Cd151 |
CD151 antigen |
62 |
0.89 |
chr1_136142237_136142876 | 5.85 |
Kif21b |
kinesin family member 21B |
11102 |
0.11 |
chr6_42709318_42710223 | 5.84 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
301 |
0.81 |
chr10_81464661_81465630 | 5.79 |
Gm16105 |
predicted gene 16105 |
3986 |
0.08 |
chrY_90760297_90760986 | 5.65 |
Gm21860 |
predicted gene, 21860 |
5174 |
0.19 |
chr6_22794374_22794759 | 5.60 |
Gm25942 |
predicted gene, 25942 |
4748 |
0.17 |
chr16_44687184_44688343 | 5.50 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr12_12220796_12221120 | 5.48 |
Fam49a |
family with sequence similarity 49, member A |
41181 |
0.19 |
chr10_69706422_69706805 | 5.46 |
Ank3 |
ankyrin 3, epithelial |
135 |
0.98 |
chr17_83889634_83890169 | 5.42 |
1810073O08Rik |
RIKEN cDNA 1810073O08 gene |
28036 |
0.12 |
chr7_25009088_25009379 | 5.36 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
3275 |
0.14 |
chr15_25754647_25755340 | 5.33 |
Myo10 |
myosin X |
2014 |
0.38 |
chr14_121172063_121172458 | 5.32 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
70181 |
0.11 |
chr13_84448589_84449243 | 5.26 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr9_89842374_89842823 | 5.24 |
4930524O08Rik |
RIKEN cDNA 4930524O08 gene |
15616 |
0.16 |
chr7_61939801_61940302 | 5.16 |
Mir344-2 |
microRNA 344-2 |
55 |
0.95 |
chr10_3863520_3864007 | 5.16 |
Gm16149 |
predicted gene 16149 |
5844 |
0.21 |
chr10_38553865_38554067 | 5.16 |
Gm22911 |
predicted gene, 22911 |
61515 |
0.14 |
chr13_26656976_26657325 | 5.15 |
Gm47883 |
predicted gene, 47883 |
23543 |
0.23 |
chr13_15759168_15760299 | 5.14 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr17_13586214_13586541 | 5.11 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
17513 |
0.15 |
chr6_124915577_124916697 | 5.11 |
Ptms |
parathymosin |
608 |
0.37 |
chr12_29547825_29548188 | 5.10 |
Myt1l |
myelin transcription factor 1-like |
12784 |
0.23 |
chr12_111758304_111760062 | 5.09 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr12_29279690_29280795 | 5.08 |
Gm6989 |
predicted gene 6989 |
37326 |
0.21 |
chr6_66399474_66399715 | 5.08 |
Gm44233 |
predicted gene, 44233 |
848 |
0.4 |
chr6_124463856_124464600 | 5.06 |
Clstn3 |
calsyntenin 3 |
127 |
0.92 |
chrX_94462999_94463548 | 5.05 |
AL627302.1 |
melanoma antigen family D, 4 pseudogene |
3134 |
0.16 |
chr1_85600326_85601326 | 5.04 |
Sp140 |
Sp140 nuclear body protein |
123 |
0.9 |
chr10_89872532_89872800 | 5.04 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
843 |
0.68 |
chr13_63918756_63919481 | 5.03 |
Ercc6l2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 like 2 |
25091 |
0.15 |
chr14_77377991_77378204 | 5.01 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
2482 |
0.31 |
chr15_44706767_44707004 | 4.99 |
Sybu |
syntabulin (syntaxin-interacting) |
40903 |
0.15 |
chr9_13246797_13247848 | 4.96 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr3_86786918_86787697 | 4.95 |
Dclk2 |
doublecortin-like kinase 2 |
5008 |
0.21 |
chr9_45663652_45664379 | 4.85 |
Dscaml1 |
DS cell adhesion molecule like 1 |
8822 |
0.19 |
chr7_39487201_39487860 | 4.83 |
Gm28455 |
predicted gene 28455 |
1908 |
0.24 |
chr7_31127074_31128340 | 4.83 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr2_53437450_53438022 | 4.80 |
Gm13501 |
predicted gene 13501 |
39249 |
0.2 |
chr2_142731762_142732107 | 4.79 |
Kif16b |
kinesin family member 16B |
29263 |
0.21 |
chr6_89351482_89352324 | 4.75 |
Plxna1 |
plexin A1 |
5814 |
0.17 |
chr1_158547693_158547874 | 4.71 |
Gm37848 |
predicted gene, 37848 |
4183 |
0.17 |
chr8_4492910_4494136 | 4.71 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr10_78787742_78788305 | 4.70 |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
7321 |
0.14 |
chr8_6207539_6207933 | 4.68 |
Gm44842 |
predicted gene 44842 |
10932 |
0.24 |
chr6_50776731_50777167 | 4.66 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
625 |
0.69 |
chr5_116591724_116592384 | 4.66 |
Srrm4 |
serine/arginine repetitive matrix 4 |
237 |
0.93 |
chr8_12873206_12874084 | 4.65 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr10_106609605_106610022 | 4.65 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
7333 |
0.29 |
chr7_83631542_83632451 | 4.64 |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
4 |
0.6 |
chr2_94246412_94247550 | 4.63 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3643 |
0.17 |
chr10_118121607_118122166 | 4.62 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
9369 |
0.16 |
chr11_5788301_5789276 | 4.60 |
Dbnl |
drebrin-like |
258 |
0.86 |
chr11_32087496_32088333 | 4.60 |
Gm12108 |
predicted gene 12108 |
13314 |
0.2 |
chr1_5022831_5023607 | 4.59 |
Rgs20 |
regulator of G-protein signaling 20 |
3680 |
0.21 |
chrX_81070276_81071390 | 4.58 |
Tmem47 |
transmembrane protein 47 |
117 |
0.98 |
chr14_64595318_64595919 | 4.58 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr9_83806172_83806700 | 4.56 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr14_119857299_119857740 | 4.56 |
4930404K13Rik |
RIKEN cDNA 4930404K13 gene |
58541 |
0.13 |
chr19_10041145_10042475 | 4.54 |
Fads3 |
fatty acid desaturase 3 |
78 |
0.96 |
chr13_40606396_40606745 | 4.53 |
Gm47039 |
predicted gene, 47039 |
91 |
0.97 |
chr16_35581258_35581604 | 4.53 |
Gm5963 |
predicted pseudogene 5963 |
7875 |
0.19 |
chr5_38158989_38159808 | 4.52 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr5_30712274_30713396 | 4.51 |
Dpysl5 |
dihydropyrimidinase-like 5 |
934 |
0.49 |
chr5_24423517_24424454 | 4.51 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
126 |
0.78 |
chr15_85403238_85403735 | 4.46 |
Gm23517 |
predicted gene, 23517 |
52232 |
0.12 |
chr5_27049317_27050134 | 4.45 |
Dpp6 |
dipeptidylpeptidase 6 |
332 |
0.92 |
chr16_85092305_85093056 | 4.45 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr3_108433472_108434154 | 4.43 |
Gm22942 |
predicted gene, 22942 |
7517 |
0.09 |
chr1_14755119_14756069 | 4.43 |
Gm9947 |
predicted gene 9947 |
140 |
0.64 |
chr6_18446901_18447365 | 4.41 |
Gm26233 |
predicted gene, 26233 |
2207 |
0.27 |
chr4_110050502_110051534 | 4.41 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr15_85677865_85678230 | 4.39 |
Lncppara |
long noncoding RNA near Ppara |
24431 |
0.12 |
chr10_59090889_59091164 | 4.39 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
10992 |
0.24 |
chr17_13587362_13587709 | 4.39 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
18671 |
0.15 |
chr15_50997219_50997761 | 4.37 |
Gm48913 |
predicted gene, 48913 |
99851 |
0.08 |
chr8_69160881_69161314 | 4.37 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
20144 |
0.15 |
chr13_103114400_103114693 | 4.36 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
17701 |
0.25 |
chr12_119945594_119946245 | 4.36 |
Tmem196 |
transmembrane protein 196 |
38 |
0.98 |
chr14_14350947_14351733 | 4.36 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr1_193369767_193370837 | 4.35 |
Camk1g |
calcium/calmodulin-dependent protein kinase I gamma |
4 |
0.97 |
chr2_126932364_126933545 | 4.35 |
Sppl2a |
signal peptide peptidase like 2A |
281 |
0.9 |
chr4_20777672_20778960 | 4.34 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chrX_74282355_74283413 | 4.33 |
Taz |
tafazzin |
37 |
0.86 |
chr11_43548063_43548966 | 4.33 |
Ccnjl |
cyclin J-like |
19268 |
0.13 |
chr18_5207665_5208009 | 4.33 |
Gm26682 |
predicted gene, 26682 |
42106 |
0.18 |
chr17_56472537_56473329 | 4.33 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr12_68599657_68600146 | 4.32 |
n-R5s61 |
nuclear encoded rRNA 5S 61 |
1069 |
0.55 |
chr18_40459021_40459343 | 4.31 |
Gm31019 |
predicted gene, 31019 |
19445 |
0.22 |
chr11_88582890_88583759 | 4.31 |
Msi2 |
musashi RNA-binding protein 2 |
6823 |
0.27 |
chr14_66319706_66319909 | 4.30 |
Gm41183 |
predicted gene, 41183 |
21422 |
0.13 |
chr2_127521161_127522051 | 4.29 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr11_32158605_32158866 | 4.29 |
Gm12109 |
predicted gene 12109 |
26270 |
0.12 |
chr1_74103754_74104304 | 4.26 |
Tns1 |
tensin 1 |
5353 |
0.18 |
chr3_107793294_107794069 | 4.26 |
Gm43233 |
predicted gene 43233 |
11825 |
0.12 |
chr7_58788607_58788797 | 4.25 |
Gm6226 |
predicted gene 6226 |
49236 |
0.11 |
chr11_8445929_8446368 | 4.24 |
Tns3 |
tensin 3 |
22527 |
0.25 |
chr17_24736037_24737110 | 4.23 |
Msrb1 |
methionine sulfoxide reductase B1 |
69 |
0.91 |
chr15_98983244_98983754 | 4.21 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
128 |
0.91 |
chr15_32003204_32003389 | 4.20 |
Gm49285 |
predicted gene, 49285 |
46655 |
0.18 |
chr14_55116352_55116664 | 4.19 |
Jph4 |
junctophilin 4 |
72 |
0.94 |
chr16_17987771_17988057 | 4.16 |
Vpreb2 |
pre-B lymphocyte gene 2 |
7486 |
0.13 |
chr12_11436450_11436779 | 4.13 |
Vsnl1 |
visinin-like 1 |
1 |
0.97 |
chr4_125545547_125545968 | 4.13 |
Mir692-2 |
microRNA 692-2 |
41008 |
0.15 |
chr7_129937635_129938453 | 4.11 |
Gm4265 |
predicted gene 4265 |
24121 |
0.24 |
chr16_33606719_33607344 | 4.11 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9359 |
0.26 |
chr2_51066696_51066895 | 4.10 |
Rnd3 |
Rho family GTPase 3 |
82299 |
0.1 |
chr12_44329338_44330111 | 4.09 |
Nrcam |
neuronal cell adhesion molecule |
474 |
0.8 |
chr4_53253649_53254014 | 4.09 |
4930522O17Rik |
RIKEN cDNA 4930522O17 gene |
7635 |
0.18 |
chr7_83201618_83202091 | 4.09 |
5930435M05Rik |
RIKEN cDNA 5930435M05 gene |
268 |
0.92 |
chr4_62942368_62942598 | 4.09 |
Gm11480 |
predicted gene 11480 |
2571 |
0.2 |
chr8_4192812_4193553 | 4.09 |
Evi5l |
ecotropic viral integration site 5 like |
1890 |
0.19 |
chr1_85588537_85589247 | 4.07 |
Sp110 |
Sp110 nuclear body protein |
299 |
0.81 |
chr13_91915980_91916295 | 4.07 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
39252 |
0.15 |
chr11_31999868_32000096 | 4.07 |
Nsg2 |
neuron specific gene family member 2 |
481 |
0.83 |
chr9_26519987_26520600 | 4.06 |
Gm30313 |
predicted gene, 30313 |
29660 |
0.23 |
chr14_78383257_78383728 | 4.06 |
Gm26197 |
predicted gene, 26197 |
72152 |
0.09 |
chr7_51749835_51750061 | 4.06 |
Gm7336 |
predicted gene 7336 |
3301 |
0.23 |
chr13_83727309_83727854 | 4.06 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
525 |
0.66 |
chr2_48318409_48318876 | 4.05 |
Gm13482 |
predicted gene 13482 |
19734 |
0.23 |
chr17_13589870_13590228 | 4.05 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
21185 |
0.15 |
chr8_13454338_13454755 | 4.04 |
Tmem255b |
transmembrane protein 255B |
932 |
0.51 |
chr9_35331151_35331788 | 4.04 |
Gm33838 |
predicted gene, 33838 |
23870 |
0.11 |
chr14_25401486_25402359 | 4.03 |
Gm26660 |
predicted gene, 26660 |
22313 |
0.15 |
chr3_34837746_34837911 | 4.03 |
Gm21388 |
predicted gene, 21388 |
678 |
0.75 |
chr1_119033632_119034415 | 4.00 |
Gli2 |
GLI-Kruppel family member GLI2 |
19316 |
0.19 |
chr18_66123896_66124047 | 3.98 |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
47568 |
0.11 |
chr11_34276626_34277049 | 3.98 |
4930403D09Rik |
RIKEN cDNA 4930403D09 gene |
22870 |
0.17 |
chr15_84106045_84106196 | 3.96 |
Sult4a1 |
sulfotransferase family 4A, member 1 |
366 |
0.57 |
chr15_56278004_56278392 | 3.96 |
Hba-ps3 |
hemoglobin alpha, pseudogene 3 |
105809 |
0.07 |
chr18_15174619_15175056 | 3.96 |
Gm2629 |
predicted gene 2629 |
19945 |
0.17 |
chr15_86419577_86420037 | 3.96 |
A930001M01Rik |
RIKEN cDNA A930001M01 gene |
55288 |
0.15 |
chr7_96290790_96290962 | 3.95 |
Mir6394 |
microRNA 6394 |
14791 |
0.2 |
chr10_81364518_81366962 | 3.94 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr2_137939077_137939470 | 3.93 |
Gm14062 |
predicted gene 14062 |
62442 |
0.16 |
chr8_23669523_23669919 | 3.93 |
Zmat4 |
zinc finger, matrin type 4 |
47 |
0.98 |
chr2_107290011_107290681 | 3.93 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
293 |
0.95 |
chr3_137680957_137681359 | 3.91 |
Gm21962 |
predicted gene, 21962 |
9634 |
0.14 |
chr12_29871996_29872873 | 3.91 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr16_14265466_14265813 | 3.91 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr13_52457883_52458068 | 3.91 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr14_25586973_25588068 | 3.90 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
19837 |
0.17 |
chr7_98177614_98179153 | 3.89 |
Capn5 |
calpain 5 |
109 |
0.93 |
chr14_62585136_62585353 | 3.88 |
Gm4131 |
predicted gene 4131 |
18323 |
0.12 |
chr13_55362078_55363351 | 3.87 |
Lman2 |
lectin, mannose-binding 2 |
69 |
0.95 |
chr13_28416864_28417183 | 3.86 |
Gm40841 |
predicted gene, 40841 |
2840 |
0.33 |
chr4_136835920_136836937 | 3.85 |
Ephb2 |
Eph receptor B2 |
440 |
0.83 |
chr14_75455353_75455510 | 3.85 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
551 |
0.81 |
chr12_106130359_106130510 | 3.84 |
Gm47646 |
predicted gene, 47646 |
14966 |
0.18 |
chr14_62416217_62416427 | 3.84 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
38471 |
0.13 |
chr10_29143863_29144732 | 3.83 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr15_36967359_36968246 | 3.83 |
Gm34590 |
predicted gene, 34590 |
28938 |
0.13 |
chr18_5414467_5414898 | 3.82 |
Gm50065 |
predicted gene, 50065 |
44200 |
0.14 |
chr10_60115666_60116069 | 3.82 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
9399 |
0.18 |
chr13_83714747_83715651 | 3.82 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6182 |
0.14 |
chr14_39471742_39471933 | 3.82 |
Nrg3 |
neuregulin 3 |
829 |
0.77 |
chr14_64592292_64592443 | 3.82 |
Mir3078 |
microRNA 3078 |
1182 |
0.35 |
chr13_14522109_14522562 | 3.81 |
Gm30893 |
predicted gene, 30893 |
181 |
0.78 |
chr9_37229794_37230412 | 3.81 |
Slc37a2 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 2 |
5051 |
0.11 |
chr11_88471971_88472344 | 3.81 |
Gm11510 |
predicted gene 11510 |
38643 |
0.16 |
chr15_67898912_67899432 | 3.80 |
Gm49408 |
predicted gene, 49408 |
25344 |
0.23 |
chr8_124284873_124285143 | 3.80 |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
10095 |
0.17 |
chr18_32017434_32017762 | 3.80 |
Gm16344 |
predicted gene 16344 |
4142 |
0.15 |
chr15_18818564_18819019 | 3.79 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
17 |
0.67 |
chr10_41934443_41935500 | 3.79 |
Sesn1 |
sestrin 1 |
36598 |
0.15 |
chr19_36534720_36535517 | 3.79 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr13_83749525_83749738 | 3.78 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
10768 |
0.12 |
chr17_46027171_46027963 | 3.76 |
Vegfa |
vascular endothelial growth factor A |
2686 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.2 | 20.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.8 | 11.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
3.8 | 11.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.4 | 10.3 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
3.2 | 9.7 | GO:0021564 | vagus nerve development(GO:0021564) |
3.0 | 9.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.0 | 3.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.8 | 2.8 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
2.7 | 2.7 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.6 | 2.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.5 | 2.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.5 | 7.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.5 | 5.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
2.4 | 7.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.4 | 12.2 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.3 | 2.3 | GO:0086029 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
2.3 | 6.9 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.3 | 20.7 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
2.3 | 4.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.3 | 4.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
2.3 | 4.5 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
2.2 | 6.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.1 | 6.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.1 | 4.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.1 | 6.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
2.0 | 6.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.0 | 13.9 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
2.0 | 13.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.0 | 5.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
2.0 | 4.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.0 | 5.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.9 | 5.8 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.9 | 15.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.9 | 5.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.9 | 7.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.9 | 9.5 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.8 | 16.5 | GO:0071625 | vocalization behavior(GO:0071625) |
1.8 | 1.8 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.8 | 3.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.8 | 7.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.8 | 28.5 | GO:0008038 | neuron recognition(GO:0008038) |
1.7 | 3.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.7 | 5.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.7 | 6.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.7 | 6.8 | GO:0030035 | microspike assembly(GO:0030035) |
1.7 | 15.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.7 | 5.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.7 | 3.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.7 | 6.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.7 | 6.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.7 | 8.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.6 | 4.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.6 | 4.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.6 | 8.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.6 | 8.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.6 | 8.0 | GO:0022038 | corpus callosum development(GO:0022038) |
1.6 | 6.4 | GO:0030091 | protein repair(GO:0030091) |
1.6 | 12.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.6 | 4.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.6 | 3.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.6 | 3.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.6 | 3.1 | GO:0021586 | pons maturation(GO:0021586) |
1.6 | 4.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.6 | 1.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.6 | 9.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.6 | 4.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.5 | 3.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.5 | 10.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.5 | 3.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.5 | 6.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.5 | 4.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.5 | 3.0 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.5 | 29.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.5 | 8.7 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.4 | 2.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.4 | 4.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.4 | 5.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.4 | 12.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.3 | 4.0 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.3 | 6.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.3 | 4.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.3 | 10.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.3 | 5.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.3 | 10.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.3 | 2.6 | GO:0046959 | habituation(GO:0046959) |
1.3 | 18.3 | GO:0060384 | innervation(GO:0060384) |
1.3 | 3.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.3 | 2.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.3 | 1.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.3 | 8.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.3 | 3.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.3 | 11.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.2 | 1.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.2 | 14.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.2 | 3.7 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 3.7 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.2 | 4.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.2 | 25.4 | GO:0001964 | startle response(GO:0001964) |
1.2 | 1.2 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.2 | 4.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.2 | 2.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.2 | 60.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.2 | 1.2 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.2 | 17.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.2 | 1.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.2 | 2.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.2 | 5.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.2 | 7.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.2 | 2.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.2 | 3.5 | GO:0001927 | exocyst assembly(GO:0001927) |
1.1 | 3.4 | GO:0090427 | activation of meiosis(GO:0090427) |
1.1 | 3.4 | GO:0097503 | sialylation(GO:0097503) |
1.1 | 3.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.1 | 5.6 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.1 | 1.1 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.1 | 1.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.1 | 2.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.1 | 4.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.1 | 3.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.1 | 5.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.1 | 2.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.1 | 1.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.1 | 2.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.1 | 3.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.1 | 1.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.0 | 5.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.0 | 3.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 6.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.0 | 1.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.0 | 1.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.0 | 1.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.0 | 2.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.0 | 7.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.0 | 3.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.0 | 2.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.0 | 2.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.0 | 1.0 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.0 | 1.9 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.0 | 2.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.0 | 4.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.0 | 5.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.0 | 2.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.0 | 3.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 1.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 0.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.9 | 10.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 2.8 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.9 | 1.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.9 | 6.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.9 | 5.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.9 | 4.6 | GO:0048840 | otolith development(GO:0048840) |
0.9 | 1.8 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.9 | 3.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.9 | 2.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.9 | 1.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.9 | 2.7 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.9 | 3.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.9 | 3.5 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.9 | 1.8 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.9 | 4.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.9 | 2.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.9 | 1.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.9 | 2.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.9 | 2.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.9 | 2.6 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.8 | 61.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 5.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.8 | 11.8 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.8 | 1.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 2.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.8 | 1.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.8 | 3.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 2.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.8 | 1.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.8 | 2.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 1.6 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.8 | 8.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.8 | 1.6 | GO:0030421 | defecation(GO:0030421) |
0.8 | 3.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.8 | 5.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 2.4 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.8 | 1.6 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.8 | 1.6 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.8 | 3.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.8 | 3.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.8 | 5.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.8 | 3.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.8 | 3.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.8 | 1.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.8 | 3.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.8 | 11.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.8 | 5.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.8 | 4.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 1.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.8 | 0.8 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.8 | 1.5 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.7 | 2.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.7 | 0.7 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.7 | 1.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 10.4 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.7 | 0.7 | GO:0048382 | mesendoderm development(GO:0048382) |
0.7 | 0.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.7 | 4.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.7 | 0.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.7 | 1.5 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.7 | 6.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.7 | 2.9 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.7 | 1.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.7 | 2.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.7 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.7 | 2.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.7 | 3.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.7 | 0.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.7 | 2.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.7 | 2.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.7 | 1.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.7 | 1.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.7 | 2.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 12.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.7 | 9.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.7 | 4.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.7 | 0.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.7 | 2.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.7 | 2.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.7 | 4.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 4.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.7 | 1.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.7 | 2.7 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.7 | 2.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.7 | 2.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.7 | 1.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.7 | 3.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.7 | 0.7 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.7 | 5.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.7 | 2.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 3.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.7 | 1.3 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.7 | 2.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.7 | 2.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 1.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.6 | 3.9 | GO:0015824 | proline transport(GO:0015824) |
0.6 | 1.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 3.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.6 | 2.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 3.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 2.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 4.5 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.6 | 1.3 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.6 | 16.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.6 | 1.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.6 | 0.6 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.6 | 4.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.6 | 1.3 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 0.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 2.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 1.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.6 | 0.6 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.6 | 3.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 1.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.6 | 1.8 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.6 | 1.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 0.6 | GO:0033058 | directional locomotion(GO:0033058) |
0.6 | 8.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.6 | 0.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.6 | 2.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 1.8 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.6 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 2.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.6 | 1.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.6 | 1.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 1.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 2.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 1.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 1.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 8.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.6 | 2.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.6 | 1.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 1.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 1.7 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 0.6 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.6 | 1.7 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.6 | 7.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.6 | 1.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.6 | 0.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.6 | 0.6 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.6 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 0.6 | GO:0046958 | nonassociative learning(GO:0046958) |
0.6 | 1.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.6 | 2.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.6 | 0.6 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.5 | 1.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 4.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.5 | 1.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.5 | 8.6 | GO:0007416 | synapse assembly(GO:0007416) |
0.5 | 0.5 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 2.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 1.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.5 | 1.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 2.1 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.5 | 2.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 1.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 0.5 | GO:0002339 | B cell selection(GO:0002339) |
0.5 | 2.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 9.9 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.5 | 1.6 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.5 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.5 | 3.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 2.6 | GO:0007614 | short-term memory(GO:0007614) |
0.5 | 3.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 1.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.5 | 6.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 0.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.5 | 1.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 1.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.5 | 3.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.5 | 1.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.5 | 2.5 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.5 | 1.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 1.5 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.5 | 1.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 3.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 1.0 | GO:0098597 | observational learning(GO:0098597) |
0.5 | 2.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 1.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.5 | 1.0 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 0.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.5 | 3.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.5 | 0.9 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 0.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 2.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 1.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 2.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.5 | 0.9 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.5 | 1.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 0.5 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.5 | 1.4 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.4 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.4 | 4.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.4 | 0.4 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.4 | 1.3 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.4 | 5.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.4 | 1.3 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.4 | 1.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.4 | 2.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 1.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 2.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.4 | 0.9 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 1.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.4 | 1.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.4 | 0.9 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.4 | 0.4 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.4 | 1.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 1.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 0.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 3.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.4 | 3.0 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 0.8 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 0.8 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.4 | 30.9 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.4 | 4.2 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.4 | 1.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 0.8 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 2.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 1.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 0.4 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 2.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 0.4 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.4 | 2.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.4 | 1.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 3.6 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.4 | 0.8 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.4 | 2.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.4 | 0.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.4 | 0.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 2.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 0.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 1.9 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.4 | 1.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 7.6 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.4 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 1.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 11.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.4 | 2.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 1.1 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 6.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.4 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.4 | 0.7 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.4 | 3.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.4 | 0.7 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.4 | 1.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 1.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 2.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.4 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.4 | 0.7 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.4 | 0.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.4 | 2.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.3 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 1.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 7.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 1.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.3 | 5.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 2.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 2.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 2.0 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.3 | 2.7 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.3 | 1.3 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.3 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 1.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 1.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 1.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 4.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 1.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 1.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 2.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 2.9 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.3 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.3 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.3 | 0.9 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 1.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 3.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.6 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 0.9 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 17.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 2.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 1.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 21.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.3 | 0.9 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 0.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.3 | 1.7 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 0.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.3 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 0.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.9 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 2.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 3.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 0.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.6 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 0.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 0.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.8 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 1.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 0.5 | GO:0002434 | immune complex clearance(GO:0002434) |
0.3 | 0.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.3 | 0.8 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 1.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 3.5 | GO:0050905 | neuromuscular process(GO:0050905) |
0.3 | 0.8 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 0.3 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.3 | GO:0060585 | vein smooth muscle contraction(GO:0014826) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 1.6 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 1.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.3 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.3 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.3 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.3 | 1.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 1.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 0.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 2.7 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 1.0 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.2 | 1.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 1.4 | GO:0001975 | response to amphetamine(GO:0001975) |
0.2 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.5 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 0.5 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.7 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.2 | 0.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 1.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 3.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 2.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 2.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.2 | 1.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 6.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 1.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.8 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.6 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.4 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 2.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 16.3 | GO:0007626 | locomotory behavior(GO:0007626) |
0.2 | 1.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.6 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.4 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 1.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 4.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.4 | GO:0086003 | cardiac muscle cell contraction(GO:0086003) |
0.2 | 3.0 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 2.6 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 1.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.2 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 0.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.4 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 4.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.5 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.5 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.0 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.9 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 1.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.3 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.1 | 2.4 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 1.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.1 | 1.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.7 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.4 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.8 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 1.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 1.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 1.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0021544 | subpallium development(GO:0021544) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 1.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.4 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.9 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.1 | 0.9 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.1 | GO:0060161 | receptor-mediated endocytosis of virus by host cell(GO:0019065) positive regulation of dopamine receptor signaling pathway(GO:0060161) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 1.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.6 | GO:0061337 | cardiac conduction(GO:0061337) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 0.8 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 3.4 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.4 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.7 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 1.6 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.4 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.4 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.2 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 1.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 1.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 0.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.1 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.1 | 1.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.3 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.1 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 1.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.6 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.7 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:1903660 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.4 | GO:0032401 | establishment of melanosome localization(GO:0032401) pigment granule transport(GO:0051904) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.0 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.0 | 0.0 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.0 | 0.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0098900 | regulation of action potential(GO:0098900) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0043366 | beta selection(GO:0043366) |
0.0 | 0.0 | GO:0015888 | thiamine transport(GO:0015888) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.7 | GO:0072534 | perineuronal net(GO:0072534) |
3.0 | 29.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.4 | 29.3 | GO:0043194 | axon initial segment(GO:0043194) |
2.4 | 14.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.2 | 10.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.1 | 14.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.0 | 2.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.0 | 6.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.8 | 31.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.8 | 16.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.7 | 3.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.7 | 5.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.7 | 1.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.7 | 1.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.6 | 6.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.5 | 4.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.5 | 4.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.4 | 5.7 | GO:0044308 | axonal spine(GO:0044308) |
1.4 | 39.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.4 | 54.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.3 | 13.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.3 | 3.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.2 | 5.9 | GO:0097433 | dense body(GO:0097433) |
1.1 | 8.0 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 3.4 | GO:0097441 | basilar dendrite(GO:0097441) |
1.1 | 16.7 | GO:0031527 | filopodium membrane(GO:0031527) |
1.1 | 1.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.0 | 7.3 | GO:0071437 | invadopodium(GO:0071437) |
1.0 | 17.5 | GO:0044295 | axonal growth cone(GO:0044295) |
1.0 | 1.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.0 | 44.1 | GO:0043198 | dendritic shaft(GO:0043198) |
1.0 | 25.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.0 | 3.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 19.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 8.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.9 | 7.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 9.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.9 | 1.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.9 | 2.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.8 | 1.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.8 | 2.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.8 | 3.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 47.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.8 | 4.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 2.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 4.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 2.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 92.9 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.7 | 5.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.7 | 8.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.7 | 2.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.6 | 1.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 1.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 1.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.6 | 57.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 1.7 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.6 | 1.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 4.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 3.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.5 | 43.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.5 | 1.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 1.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 2.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 1.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 3.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.5 | 1.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 1.4 | GO:0071942 | XPC complex(GO:0071942) |
0.5 | 4.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 1.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 2.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 2.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 4.9 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 5.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 1.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 1.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 6.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 1.6 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 1.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 1.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.4 | 1.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 19.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.4 | 10.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 1.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 2.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 2.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 4.1 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 2.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 4.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.3 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.6 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 0.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 3.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 18.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 2.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 0.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.3 | 63.7 | GO:0045202 | synapse(GO:0045202) |
0.3 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 0.8 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 3.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 1.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 2.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 2.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 2.5 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 3.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 5.3 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 2.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.2 | GO:0070187 | telosome(GO:0070187) |
0.2 | 1.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 20.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 5.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 1.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 2.0 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 3.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.1 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 3.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 4.6 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.5 | 13.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
4.4 | 13.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.6 | 14.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.5 | 17.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.2 | 15.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.8 | 8.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.6 | 10.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
2.6 | 18.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.6 | 12.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.5 | 10.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.4 | 2.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.3 | 6.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.2 | 6.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.2 | 15.5 | GO:0003680 | AT DNA binding(GO:0003680) |
2.2 | 4.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.2 | 17.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
2.2 | 6.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.1 | 6.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.0 | 10.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.9 | 5.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.9 | 3.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 9.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.9 | 35.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.9 | 14.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.8 | 9.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.7 | 10.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.6 | 6.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.6 | 6.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.6 | 7.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.5 | 4.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.5 | 7.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.5 | 4.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.4 | 5.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.4 | 4.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.3 | 3.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 6.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.2 | 2.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.2 | 3.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.2 | 2.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.2 | 4.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.1 | 5.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.1 | 3.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.1 | 11.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.1 | 13.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.1 | 3.3 | GO:0051373 | FATZ binding(GO:0051373) |
1.1 | 4.4 | GO:0097001 | ceramide binding(GO:0097001) |
1.0 | 3.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.0 | 3.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.0 | 33.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.0 | 3.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 3.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.0 | 3.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.0 | 13.5 | GO:0031402 | sodium ion binding(GO:0031402) |
1.0 | 6.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.9 | 2.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.9 | 2.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.9 | 4.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.9 | 3.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.9 | 9.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.9 | 5.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 2.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.9 | 3.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 2.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.9 | 11.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.9 | 20.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 4.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.9 | 3.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.8 | 2.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 9.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.8 | 3.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 6.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 4.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.8 | 8.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.8 | 2.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.8 | 3.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 3.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 2.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.7 | 8.8 | GO:0031005 | filamin binding(GO:0031005) |
0.7 | 2.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 7.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.7 | 2.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.7 | 4.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 6.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 2.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.7 | 6.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.7 | 15.2 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.7 | 4.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.7 | 0.7 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.7 | 2.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 6.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.7 | 3.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.7 | 2.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.7 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 5.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.6 | 1.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 19.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 2.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.6 | 11.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 1.8 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.6 | 3.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 1.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.6 | 6.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.6 | 0.6 | GO:0051870 | methotrexate binding(GO:0051870) |
0.6 | 2.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.6 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.5 | 4.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 1.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.5 | 1.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 2.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 15.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 3.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 1.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 5.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 6.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 3.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 1.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 1.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 8.7 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.5 | 4.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.5 | 1.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 1.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 2.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 5.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 2.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 5.2 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.4 | 1.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 6.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 8.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 7.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 3.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 1.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 1.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 1.3 | GO:0018589 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.4 | 0.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 10.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 2.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 0.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 1.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 2.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 6.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.4 | 7.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.4 | 3.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 1.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.4 | 3.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 5.4 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 1.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 4.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 7.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 0.8 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.4 | 1.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 3.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 7.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 4.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.4 | 1.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 6.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 3.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.7 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 2.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 1.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 2.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 10.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 0.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 3.3 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.2 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 0.9 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.3 | 9.8 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 1.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 4.0 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 1.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 1.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 2.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 0.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 2.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 9.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 1.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 0.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 2.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.3 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 2.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 2.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 1.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 11.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 2.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.5 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 2.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 2.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 1.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 0.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.7 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.2 | 8.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 0.9 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 12.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 6.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 4.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.6 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 2.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 0.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 1.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 25.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 1.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 3.8 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 5.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 4.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 0.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 3.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 3.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.7 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 1.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 6.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 1.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 2.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 1.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 3.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 7.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.5 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.7 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.4 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 36.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.0 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.8 | 11.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 2.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.7 | 10.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 0.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 14.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 6.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 12.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 10.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 9.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 7.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 18.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 11.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 3.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 3.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 3.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 0.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 1.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 2.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 5.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 4.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 3.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 6.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 11.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 37.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.6 | 30.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.8 | 26.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.6 | 1.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.6 | 4.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.4 | 32.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 5.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.3 | 14.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.2 | 50.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 19.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.0 | 5.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
1.0 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.9 | 10.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.9 | 13.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.9 | 12.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 10.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.8 | 15.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 6.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 16.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.7 | 2.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.6 | 7.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 20.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 1.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.6 | 0.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 6.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 4.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 8.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 11.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 3.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 0.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 5.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 7.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 2.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 5.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 0.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 5.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 3.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.4 | 3.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 4.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 3.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 6.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 4.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 4.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 10.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 10.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 1.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 4.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 5.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 1.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 4.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 3.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 3.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 2.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 1.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 1.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 1.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 2.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 3.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 4.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 2.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.4 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.8 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |